The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen-and-treat strategies

International Journal of Cancer

Volumn 130, Issue 9, 2012, Pages 2111-2117

  Gage, Julia C ^a   Ajenifuja, Kayode O ^b   Wentzensen, Nicolas A ^a   Adepiti, Akinfolarin C ^b   Eklund, Claire ^c   Reilly, Mary ^c   Hutchinson, Martha ^c   Wacholder, Sholom ^a   Harford, Joe ^a   Soliman, Amr S ^d   Burk, Robert D ^e   Schiffman, Mark ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c Infants Hospital   (United States)

^d UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

age; HPV prevalence; screening

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER SCREENING; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; NIGERIA; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RANDOM SAMPLE; RURAL AREA; TREATMENT PLANNING; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CYTODIAGNOSIS; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; NIGERIA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84857471099     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26211     Document Type: Article

References (29)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N,. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
2. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, Scott DR, Sherman ME, Kurman RJ, Wacholder S, Stanton CK, Manos MM,. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-64.
3. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ,. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
4. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D,. GLOBOCAN 2008: cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2008.
5. Gustafsson L, Ponten J, Zack M, Adami HO,. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997; 8: 755-63.
6. Gustafsson L, Ponten J, Bergstrom R, Adami HO,. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997; 71: 159-65.
7. Denny L, Quinn M, Sankaranarayanan R,. Chapter 8: Screening for cervical cancer in developing countries. Vaccine 2006; 24 (Suppl 3): S71-S77.
8. Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC, Jr,. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst 2010; 102: 1557-67.
9. Smith JS, Melendy A, Rana RK, Pimenta JM,. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008; 43: S5-S25, S25 e1-e41.
10. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008; 337: a1754.
11. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M,. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003; 95: 46-52.
12. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-94.
13. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, Wright TC,. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005; 353: 2158-68.
14. Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S,. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 2007; 121: 1306-11.
15. Franceschi S, Rajkumar R, Snijders PJ, Arslan A, Mahe C, Plummer M, Sankaranarayanan R, Cherian J, Meijer CJ, Weiderpass E,. Papillomavirus infection in rural women in southern India. Br J Cancer 2005; 92: 601-6.
16. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Munoz N, Snijders PJF, Meijer C, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004; 90: 638-45.
17. Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, van Kemenade FJ, Snijders PJF, Meijer C, Franceschi S,. HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer 2009; 101: 202-8.
18. Wall SR, Scherf CF, Morison L, Hart KW, West B, Ekpo G, Fiander AN, Man S, Gelder CM, Walraven G, Borysiewicz LK,. Cervical human papillomavirus infection and squamous intraepithelial lesions in rural Gambia, West Africa: viral sequence analysis and epidemiology. Br J Cancer 2005; 93: 1068-76.
19. Castle PE, Schiffman M, Gravitt PE, Kendall H, Fishman S, Dong H, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Lorincz A, Schussler JE, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol 2002; 68: 417-23.
20. Gravitt PE, Burk RD, Lorincz A, Herrero R, Hildesheim A, Sherman ME, Bratti MC, Rodriguez AC, Helzlsouer KJ, Schiffman M,. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 2003; 12: 477-84.
21. Ferenczy A,. Comparison of cryo- and carbon dioxide laser therapy for cervical intraepithelial neoplasia. Obstet Gynecol 1985; 66: 793-8.
22. Andersen ES, Husth M,. Cryosurgery for cervical intraepithelial neoplasia: 10-year follow-up. Gynecol Oncol 1992; 45: 240-2.
23. Kwikkel HJ, Helmerhorst TJ, Bezemer PD, Quaak MJ, Stolk JG,. Laser or cryotherapy for cervical intraepithelial neoplasia: a randomized study to compare efficacy and side effects. Gynecol Oncol 1985; 22: 23-31.
24. Hemmingsson E, Stenson S,. The results of cryosurgical treatment in young women with cervical intra-epithelial neoplasia. Acta Obstet Gynecol Scand 1983; 62: 39-42.
25. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119: 2677-84.
26. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD,. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 1796-807.
27. Baay MF, Kjetland EF, Ndhlovu PD, Deschoolmeester V, Mduluza T, Gomo E, Friis H, Midzi N, Gwanzura L, Mason PR, Vermorken JB, Gundersen SG,. Human papillomavirus in a rural community in Zimbabwe: the impact of HIV co-infection on HPV genotype distribution. J Med Virol 2004; 73: 481-5.
28. Castellsague X, Menendez C, Loscertales MP, Kornegay JR, dos Santos F, Gomez-Olive FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P,. Human papillomavirus genotypes in rural Mozambique. Lancet 2001; 358: 1429-30.
29. Didelot-Rousseau MN, Nagot N, Costes-Martineau V, Valles X, Ouedraogo A, Konate I, Weiss HA, Van de Perre P, Mayaud P, Segondy M,. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer 2006; 95: 355-62.